Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Open in API
Filings indexed 1,213 across all filing types
Latest filing 2023-05-05 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for SSY Group Limited. It references specific listing rules from the Stock Exchange of Hong Kong (Main Board Listing Rules and GEM Listing Rules) and details repurchase of shares and cancellation. The content is focused on reporting changes in share capital and share repurchases, including confirmations by the board. This matches the description of announcements regarding share repurchases or capital changes. The document is not a full financial report but a regulatory disclosure of share capital changes. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support a confident classification.
2023-05-05 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return on movements in securities for SSY Group Limited, including authorized share capital, issued shares, share options, repurchases, and confirmations related to securities issued. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content focuses on share capital changes, share options, repurchases, and confirmations of compliance rather than financial performance, earnings, or management commentary. It is not an annual or interim report, earnings release, or management discussion. It is a regulatory filing reporting share capital movements and confirmations, fitting the category of Regulatory Filings (RNS). The document length (9029 characters) and detailed tabular data support this classification rather than a brief announcement or report publication notice.
2023-05-02 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by the board of directors regarding an update on product development, specifically the approval of L-Malic acid as a bulk drug. It is not a financial report, regulatory filing, or any form of meeting material. The document is short (1968 characters) and serves to inform shareholders and investors about business developments rather than financial results or governance changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2023-04-28 English
UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2023
Interim / Quarterly Report Classification · 95% confidence The document is an announcement of unaudited operating results for the three months ended 31 March 2023. It explicitly states that the financial information is unaudited and based on management accounts, and it cautions that this information should not be regarded as the audited financial results. The document provides detailed financial data for the quarter, including turnover, gross profit, and profit attributable to shareholders, which are typical contents of an interim or quarterly report. The length of the document (4647 characters) and the detailed financial data indicate it is a substantive financial report rather than a brief announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-04-25 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by the board of directors regarding an update on product development, specifically approvals for drug production and registration. It is not a financial report, earnings release, or regulatory filing related to financial performance. The document is short (1755 characters) and serves to inform shareholders and investors about business developments rather than financial results or governance changes. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is an announcement of business development, which aligns best with the Regulatory Filings (RNS) category as a general regulatory announcement that does not fit other specific categories.
2023-04-20 English
Proxy Form for Annual General Meeting 2023
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for the Annual General Meeting (AGM) 2023 of SSY Group. It includes instructions for shareholders to appoint proxies to vote on various resolutions at the AGM, including adoption of financial statements, re-election of directors, appointment of auditors, dividend declaration, and share issuance mandates. The content is procedural and related to voting at the AGM rather than the actual AGM materials or reports. It is not the AGM presentation or minutes, nor is it an annual report or financial statement. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2023-04-18 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.